Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
- PMID: 20300369
- PMCID: PMC2840915
- DOI: 10.4103/0974-2077.53097
Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
Abstract
Serenoa repens is one among the many naturally occurring 5 alpha reductase (5aR) inhibitors which has gained popularity as a magical remedy for androgenetic alopecia. It is widely advertised on the web and sold by direct marketing. Used as a self-medication, there is a risk of missing the early detection of prostate cancer. There is little evidence to support its efficacy, warranting larger clinical trials on androgenetic alopecia.
Keywords: 5 alpha reductase; Androgenetic alopecia; serenoa repens.
Conflict of interest statement
Figures
References
-
- Prager N. A randomized double-blind placebo controlled trial to determine the effectiveness of botanically derived inhibitors of 5 alpha reductase in the treatment of androgenetic alopecia. J Altern Complent Med. 2002;8:413–52. - PubMed
-
- Fasculo C. Effectiveness of serenoa repens in androgenetic alopecia. JDDG, 6.2004 (Band 2) 552 abstracts, 4th intercontinental meeting of hair research societies. 2004. Jun 17-19,
-
- Tosti A. Abstract book, 13th Annual meeting of European Hair research society. Genoa, Italy: 2008. Ketoil® shampoo (ketaconazole 0.5%, serenoa repens, taurine) Vs ketaconazole 1% shampoo (Triatop®) in patients with dandruff and seborrheic dermatitis; pp. 3–5.
LinkOut - more resources
Full Text Sources
Other Literature Sources